NextPlat (NXPL) Share-based Compensation Growth (3y) (2014 - 2026)
Powered by 
Analysis
NextPlat (NXPL) Share-based Compensation Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 10.06% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -8.13% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -7.97% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -70.06% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 17.84% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 29.52% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 53.88% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 12.93% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | -48.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -48.46% |
| Mar 31, 2026 | 2.41% |
| Dec 31, 2025 | -36.17% |
| Sep 30, 2025 | -31.71% |
| Jun 30, 2025 | 26.11% |
| Mar 31, 2025 | -82.90% |
| Dec 31, 2024 | -26.12% |
| Sep 30, 2024 | -17.56% |
| Jun 30, 2024 | -0.24% |
| Mar 31, 2024 | -41.13% |
| Dec 31, 2023 | 5.18% |
| Sep 30, 2023 | 98.34% |
| Jun 30, 2023 | 527.16% |
| Mar 31, 2023 | 173.03% |
| Sep 30, 2022 | 154.50% |
| Dec 31, 2021 | 169.83% |
| Sep 30, 2021 | 15.10% |
| Jun 30, 2021 | -0.64% |
| Dec 31, 2020 | -25.72% |
| Sep 30, 2020 | -80.35% |